Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2441072
Max Phase: Preclinical
Molecular Formula: C10H11N3O4S
Molecular Weight: 269.28
Molecule Type: Small molecule
Associated Items:
ID: ALA2441072
Max Phase: Preclinical
Molecular Formula: C10H11N3O4S
Molecular Weight: 269.28
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=[N+]([O-])c1ccc2c(c1)S(=O)(=O)NCN2C1CC1
Standard InChI: InChI=1S/C10H11N3O4S/c14-13(15)8-3-4-9-10(5-8)18(16,17)11-6-12(9)7-1-2-7/h3-5,7,11H,1-2,6H2
Standard InChI Key: HHEDIWRTQHXSNJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 269.28 | Molecular Weight (Monoisotopic): 269.0470 | AlogP: 0.81 | #Rotatable Bonds: 2 |
Polar Surface Area: 92.55 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.60 | CX Basic pKa: | CX LogP: 1.26 | CX LogD: 1.25 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.63 | Np Likeness Score: -1.18 |
1. Nørholm AB, Francotte P, Olsen L, Krintel C, Frydenvang K, Goffin E, Challal S, Danober L, Botez-Pop I, Lestage P, Pirotte B, Kastrup JS.. (2013) Synthesis, pharmacological and structural characterization, and thermodynamic aspects of GluA2-positive allosteric modulators with a 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide scaffold., 56 (21): [PMID:24131202] [10.1021/jm4012092] |
Source(1):